Major NIH-Funded Study Highlights Potential Clinical Application of AtCor Medical Holdings Limited’s SphygmoCor(R) System

SYDNEY, AUSTRALIA and LISLE, IL--(MARKET WIRE)--Jun 7, 2007 -- AtCor Medical Holdings Limited (ASX:ACG.AX - News), the developer and marketer of the SphygmoCor® system, which non-invasively measures central blood pressures, today announced that the Strong Heart Study, a major multi-year study funded by the U.S. National Institutes of Health, concludes that central blood pressures are more predictive of future cardiovascular outcomes than traditional brachial (cuff) blood pressure. The study was published online in the American Heart Association journal, Hypertension, and will also be featured in the July 2007 print edition.

MORE ON THIS TOPIC